Dirk Nagorsen

Summary

Publications

  1. doi Immunomodulatory therapy of cancer with T cell-engaging BiTE antibody blinatumomab
    Dirk Nagorsen
    Micromet, Inc, 6707 Democracy Blvd, Bethesda, MD 20817, USA
    Exp Cell Res 317:1255-60. 2011

Detail Information

Publications1

  1. doi Immunomodulatory therapy of cancer with T cell-engaging BiTE antibody blinatumomab
    Dirk Nagorsen
    Micromet, Inc, 6707 Democracy Blvd, Bethesda, MD 20817, USA
    Exp Cell Res 317:1255-60. 2011
    ..High response rates and durable remissions are observed in first clinical trials, indicating that T cells can be potently redirected for efficient and lasting elimination of malignant cells...